de Vries, A. G. S. (2024). Diabetes care in hospitals across the Netherlands: Real-world data and diabetes registry insights. [Thesis, fully internal, Universiteit van Amsterdam].
Ahdi, M. (2024). CSI Slotervaart: Clinical findings from a multiethnic diabetes cohort in Amsterdam. [Thesis, fully internal, Universiteit van Amsterdam].
Warmbrunn, M. V. (2024). A kick in the guts: Insulin resistance, gut microbiota and cardiometabolic diseases. [Thesis, fully internal, Universiteit van Amsterdam].
Balvers, M. (2024). The human genome and microbiome in cardiometabolic disease: Exploration through sequence-based technologies. [Thesis, fully internal, Universiteit van Amsterdam].
Habibe, J. J. (2023). The emerging role of FHL2 in metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
van Dijk, A.-M. (2023). Navigating NAFLD non-invasively: Ingredients to shape future care paths in non-alcoholic fatty liver disease. [Thesis, fully internal, Universiteit van Amsterdam].
Meiring, S. (2023). Clinical and mechanistic studies of duodenal mucosal resurfacing for type 2 diabetes. [Thesis, fully internal, Universiteit van Amsterdam].
Mens, M. A. (2023). Innovative CT in diabetic foot disease: A multidisciplinary approach. [Thesis, fully internal, Universiteit van Amsterdam].
Mak, A. L. (2023). Metabolic dysfunction-associated steatotic liver disease: A wide-angled perspective on a multifaceted problem. [Thesis, fully internal, Universiteit van Amsterdam].
Meijnikman, A. S. (2023). A panomics step to unravel the role of gut microbiota in metabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
